XML 50 R39.htm IDEA: XBRL DOCUMENT v3.22.1
ISSUANCE OF EQUITY SECURITIES (Details Narrative)
 3 Months Ended 6 Months Ended
Mar. 17, 2022
shares
Dec. 28, 2021
USD ($)
Mar. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Mar. 31, 2022
USD ($)
shares
Class of Warrant or Right [Line Items]          
Proceeds from exercise of warrants, net of issuance costs | $         $ 1,702,596
Aggregate offering price | $     $ 11,017,304 $ 2,683,980  
Independent Director Five [Member] | 2013 Stock Incentive Plan [Member]          
Class of Warrant or Right [Line Items]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period 23,584        
Five Independent Directors [Member] | 2013 Stock Incentive Plan [Member]          
Class of Warrant or Right [Line Items]          
Compensation paid to agent | $         $ 9,590
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period 117,920        
Equity Distribution Agreement [Member]          
Class of Warrant or Right [Line Items]          
Percentage of commission to agent   0.030      
Equity Distribution Agreement [Member] | At-The-Market Offering [Member]          
Class of Warrant or Right [Line Items]          
Aggregate offering price | $   $ 20,000,000      
Number of common stock issued and sold         42,448
Proceeds from issuance and sale of common stock | $         $ 88,426
Compensation paid to agent | $         $ 2,735
2021 Warrants [Member]          
Class of Warrant or Right [Line Items]          
Shares issued for exercise of warrants         384,447
Series A Warrant [Member]          
Class of Warrant or Right [Line Items]          
Shares issued for exercise of warrants         380,447
Number of warrants exercised         380,447
Series B Warrant [Member]          
Class of Warrant or Right [Line Items]          
Shares issued for exercise of warrants         4,000
Number of warrants exercised         8,000